Quick Answer
Aprea Therapeutics, Inc. reported Stockholders Equity of $12.44 million for fiscal year 2025.
Aprea Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $12.44M | -35.6% |
| 2024 | $19.31M | +13.9% |
| 2023 | $16.95M | -33.9% |
| 2022 | $25.64M | -48.2% |
| 2021 | $49.51M | -36.0% |
| 2020 | $77.40M | -37.7% |
| 2019 | $124.24M | +341.5% |
| 2018 | -$51.44M | -43.8% |
| 2017 | -$35.77M | -66.6% |
| 2016 | -$21.47M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.91M | -50.3% | -18.6% |
| June 30, 2025 | $13.41M | -47.5% | -13.7% |
| March 31, 2025 | $15.55M | -46.2% | -19.5% |
| December 31, 2024 | $19.31M | +13.9% | -12.0% |
| September 30, 2024 | $21.95M | +8.2% | -14.1% |
| June 30, 2024 | $25.56M | +9.1% | -11.6% |
| March 31, 2024 | $28.92M | +9.2% | +70.6% |
| December 31, 2023 | $16.95M | -33.9% | -16.4% |
- Aprea Therapeutics, Inc. showed a decrease of -35.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Aprea Therapeutics, Inc.’s stockholders equity has grown by 158.0% (from -$21.47 million to $12.44 million).
- The most recent figure is from Aprea Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: